The Purdue Institute for Inflammation, Immunology and Infectious Disease has named Richard Kuhn director. He is Purdue’s Trent and Judith Anderson Distinguished Professor of Science. Kuhn was part of the leadership of research teams who first determined the structures of the Zika and dengue viruses.

The Institute, which is part of Purdue’s Discovery Park, combines the university’s diverse pool of researchers in life sciences, physical sciences and engineering to invent new diagnostic tools, explore basic biological and inflammatory processes, and develop and commercialize novel intervention methods.

Among recent research projects at the institute:

• New inhalation therapies to treat multi-drug-resistant lung infections

• A low-cost method to detect preeclampsia in pregnant women

• A smartphone app that detects anemia in cancer patients undergoing chemotherapy

• A simple blood test to detect breast cancer.

The work of Purdue University’s Institute of Inflammation, Immunology and Infectious Disease has received a boost thanks to a multimillion-dollar gift from Purdue alumnus John Krenicki Jr., his wife Donna and their children.

The gift will create the Krenicki Family Directorship in Inflammation, Immunology and Infectious Disease to help provide for capable leadership of the institute as it researches the diagnosis and treatment of many of the world’s most common diseases.

In 2016 John and Donna Krenicki endowed the directorship of Purdue’s Institute for Integrative Neuroscience. In 2014 the Krenickis endowed the John and Donna Krenicki Chair in Operations Management in the Krannert School of Management.

Purdue President Mitch Daniels said the generous gift from the Krenicki family is vital for the future of Purdue’s lifesaving research in the life sciences.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}